Normal systolic function in hypertrophic cardiomyopathy: reality or myth?: reply
نویسندگان
چکیده
منابع مشابه
Bortezomib-induced Dilated cardiomyopathy – Myth or Reality
Bortezomib (Velcade) is a novel chemotherapeutic agent which has been approved since May 2003 by the US Food and Drug Administration (FDA) for the treatment of multiple myeloma in patients who have received at least two prior therapies and have demonstrated disease progression during the previous treatment. It acts through reversible inhibition of intracellular proteasomes resulting in the accu...
متن کاملContractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.
BACKGROUND Hypertrophic cardiomyopathy (HCM), typically characterized by asymmetrical left ventricular hypertrophy, frequently is caused by mutations in sarcomeric proteins. We studied if changes in sarcomeric properties in HCM depend on the underlying protein mutation. METHODS AND RESULTS Comparisons were made between cardiac samples from patients carrying a MYBPC3 mutation (MYBPC3(mut); n=1...
متن کاملThe systolic paradox in hypertrophic cardiomyopathy
OBJECTIVE We explored cardiac volumes and the effects on systolic function in hypertrophic cardiomyopathy (HCM) patients with left ventricular hypertrophy (HCM LVH+) and genotype-positive patients without left ventricular hypertrophy (HCM LVH-). METHODS We included 180 HCM LVH+, 100 HCM LVH- patients and 80 healthy individuals. End-Diastolic Volume Index (EDVI), End-Systolic Volume Index (ESV...
متن کاملMesopancreas: myth or reality?
CONTEXT A recently published study hypothesized the concept of 'mesopancreas', defining it as a firm, well-vascularized structure extending from the posterior surface of the pancreatic head to behind the mesenteric vessels. OBJECTIVE To verify and define mesopancreas from resection specimens obtained from fresh cadavers. DESIGN Postmortem anatomical-pathological study. SETTING Department ...
متن کاملMyth or Reality?
Received July 17, 2012; final revision received September 26, 2012; accepted September 27, 2012. From the Unité Neuro-Vasculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg Cedex, France (V.W.,V.L.,O.R.,M.B.,C.M.); Université de Strasbourg, EA 3072, Faculté de Médecine, Strasbourg Cedex, France (V.W.,O.R.,B.G.); and Université de Strasbourg, CNRS UMR-7237, Faculté de Médecine, Strasbourg...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2008
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehn034